Test ID: DRD4
Dopamine Receptor D4 Genotype (DRD4), Blood
Secondary ID 
A test code used for billing and in test definitions created prior to November 2011
89096
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Conditional
Useful For Suggests clinical disorders or settings where the test may be helpful
Influencing the target dose of methylphenidate treatment for patients with attention deficit/hyperactivity disorder
Determining possible cause for poor response to methylphenidate in treated patients with attention deficit/hyperactivity disorder
Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Method Name A short description of the method used to perform the test
Polymerase Chain Reaction (PCR) Followed by Sizing Analysis
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Dopamine Receptor D4 Genotype, B
Aliases Lists additional common names for a test, as an aid in searching
Dopamine
External
link
PDF
document
Excel
document
Word
document